February 1 (Wed) 2023 - March 24 (Fri) 2023, 12:00 (JST)
We will be accepting “Late Breaking Abstracts” in this meeting to provide a forum for reports on the very latest research outcomes that became available after the general abstract submission period. Please see details below. We look forward to receiving your submissions!
Please click here for the Embargo Policy of the Japan College of Rheumatology.
|No graphs, tables, or images can be included in abstracts.
|If the abstract contents are a case report, please clearly state the clinical significance of the study.
Please keep your abstract length within the following limits.
|2,000 characters, including spaces and punctuation
|No Word Limit
|Number of Authors
|Up to 30 authors
|Number of Affiliations
|Up to 20 institutions
|First author is considered as the presenting as well as corresponding author.
|Please do not include authors' information within abstract body. Any authors' information within abstract body may be deleted from publication.
|Though no word limit is set for "Abstract Title", "Authors" and "Affiliations", the contents of the abstract may be printed in small font size if the total letter number is too large.
Please submit an abstract to one of the following categories.
The first author of an abstract for the JCR annual meeting must declare any financial or personal relationships that may pose conflicts of interest upon acceptance for presentation at the annual meeting.
Please refer to the COI page for COI declaration requirements.
About COI Declaration
If you wish to withdraw your abstract, please contact the Congress Secretariat via email (firstname.lastname@example.org) during the submission period.
All submitted abstracts will be reviewed.
The result of the abstract review will be announced around the end of March to your registered email address as well as on the JCR2023 website.
Notifications will be sent by email. If you do not receive the notifications, please contact the Congress Secretariat by email: email@example.com